Use of CA125 and HE4 serum markers to predict ovarian cancer in elevated-risk women
about
MALDI-TOF-MS analysis in discovery and identification of serum proteomic patterns of ovarian cancerQuantitative analysis of cell-free DNA in ovarian cancer.Clonality analysis of synchronous gastroesophageal junction carcinoma and distal gastric cancer by whole-exome sequencing.Detection of glyco-mucin profiles improves specificity of MUC16 and MUC1 biomarkers in ovarian serous tumours.Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers.
P2860
Use of CA125 and HE4 serum markers to predict ovarian cancer in elevated-risk women
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Use of CA125 and HE4 serum markers to predict ovarian cancer in elevated-risk women
@ast
Use of CA125 and HE4 serum markers to predict ovarian cancer in elevated-risk women
@en
type
label
Use of CA125 and HE4 serum markers to predict ovarian cancer in elevated-risk women
@ast
Use of CA125 and HE4 serum markers to predict ovarian cancer in elevated-risk women
@en
prefLabel
Use of CA125 and HE4 serum markers to predict ovarian cancer in elevated-risk women
@ast
Use of CA125 and HE4 serum markers to predict ovarian cancer in elevated-risk women
@en
P2093
P2860
P1476
Use of CA125 and HE4 serum markers to predict ovarian cancer in elevated-risk women
@en
P2093
Beth Y Karlan
Charles W Drescher
Garnet Anderson
Jason Thorpe
Kate Watabayashi
M Robyn Andersen
Mary B Daly
Melanie Palomares
Nicole Urban
P2860
P304
P356
10.1158/1055-9965.EPI-13-1361
P577
2014-05-01T00:00:00Z